-

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Blue Ridge Bankshares, Inc. (BRBS)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Blue Ridge Bankshares, Inc. (“Blue Ridge” or the “Company”) (NYSE: BRBS). The investigation concerns whether Blue Ridge and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

On October 31, 2023, Blue Ridge disclosed in a filing with the U.S. Securities and Exchange Commission (“SEC”) that its management and the audit committee of its Board of Directors determined that certain specialty finance loans were reported incorrectly in the Company’s prior financial statements with the SEC. Accordingly, Blue Ridge announced that the Company’s 2022 annual report on Form 10-K and unaudited interim financial statements included in the Company’s 1Q and 2Q quarterly reports on Form 10-Q should no longer be relied upon and would be restated. Blue Ridge further advised that the adjustments included in the forthcoming restatements will result in lower reported net income and earnings per share in the 2022 fiscal year and “that a material weakness existed in the timely risk grading, nonaccrual status, and, thus, in the determination of the adequacy of the allowance for credit losses for the specialty finance portfolio of loans.”

On this news, the price of Blue Ridge shares declined by $1.06 per share, or approximately 33.65%, from $3.15 per share to close at $2.09 on November 1, 2023.

If you purchased or otherwise acquired Blue Ridge securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: https://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NYSE:BRBS

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

INVESTOR ALERT: Securities Class Action Filed Against Alight, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Alight, Inc. (“Alight” or the “Company”) (NYSE:ALIT) securities during the period of November 12, 2024 through February 18, 2026, inclusive (“the Class Period”). If you suffered a loss on your Alight investments, you have until May 15, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after...

INVESTOR ALERT: Securities Class Action Filed Against Grocery Outlet Holding Corp. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Grocery Outlet Holding Corp. (“Grocery Outlet” or the “Company”) (NASDAQ:GO) securities during the period of August 5, 2025 through March 4, 2026, inclusive (“the Class Period”). If you suffered a loss on your Grocery Outlet investments, you have until May 15, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff appl...

FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 27, 2026, Fulgent issued a press release reporting its fourth quarter and full year 20...
Back to Newsroom